Transcript Document

Title of the project elx ibris elx ibris elx ibris elx ibris elx ibris elx ibris elx ibris elx ibris elx ibris elx ibris
elx ibris elx ibris elx ibris elx ibris elx ibris elx ibris elx ibris elx ibris elx ibris [LEFT justified]
Resident’s Name, Degree(s) with periods [eg. B.Sc.(Pharm).]; Other investigators’ names [no “Dr.’s”], Degree(s) with periods. NO AFFILIATIONS.
Background
Results
 Clinical pharmacists frequently base treatment recommendations on the
primary literature.
 Recalling specific details about clinical trials is often important, though
sometimes difficult.
 Processes to provide very rapid access to the original trial data are
needed.
 A standalone PalmOS-based software application was developed using PDA Toolbox
version 4.2 for Windows.
 The application allows clinicians to enter critical data and notes from clinical trials
related to their individual practice and quickly retrieve them.
 The software automatically calculates effect sizes based on absolute incidences entered
(e.g.. RRR, RR, ARR, NNT/NNH).
 Clinical pharmacists frequently base treatment recommendations on the
primary literature.
 Recalling specific details about clinical trials is often important, though
sometimes difficult.
 Processes to provide very rapid access to the original trial data are
needed.
 Clinical pharmacists frequently base treatment recommendations on the
primary literature.
 Recalling specific details about clinical trials is often important, though
sometimes difficult.
 Processes to provide very rapid access to the original trial data are
needed.
 The software also allows entry of an individual patient’s perceived baseline risk (e.g..
based on the clinician’s suspicion or another risk estimation scheme) and applies the
trial’s effect to it, allowing individualized estimates of the magnitude/likelihood of
efficacy or harm based on the trial data.
Table 1: Trial details can be reviewed to determine applicability to the
current clinical scenario.
 The software allows the user to add “notes” to a trial where their own interpretation
and comments about the trial can be stored.
 The program is comprised of three files: A program (.prc) file (51KB) and two
database (.pdb) files (total size ~40KB, but dependent on amount of data entered).
 A standalone PalmOS-based software application was developed using PDA Toolbox
version 4.2 for Windows.
 The application allows clinicians to enter critical data and notes from clinical trials
related to their individual practice and quickly retrieve them.
Methods
 Although a database of over 950 PDF versions of clinical papers was
maintained by the author and available from any PC in the hospital, even
more rapid access to trial data while on rounds, teaching, evaluating
patients, or outside the hospital was needed.
 A précis of the critical trial data in a portable form, including a method
to estimate an individual patient’s chances of benefiting or being
harmed by a particular therapy was desired. Although a database of over
950 PDF versions of clinical papers was maintained by the author and
available from any PC in the hospital, even more rapid access to trial
data while on rounds, teaching, evaluating patients, or outside the
hospital was needed.
 A précis of the critical trial data in a portable form, including a method
to estimate an individual patient’s chances of benefiting or being
harmed by a particular therapy was desired.
AVOID 3D GRAPHICS! Keep it clean
and simple… few horizontal lines on
graphs, no background colors.
Table 2: Details of the specific trial endpoint, in a number of formats.
Figure 1: Details of the specific trial endpoint, in a number of formats.
Poster template notes: This is a 36 inch Conclusions
high (the max) by 48 inch long poster.  It is feasible to create a handheld tool for storing, retrieving and interpreting clinical
trial data.
Suggest NOT adjusting either of these

Such
a
tool
can
be
used
at
the
“point
of
curiosity”
to
improve
the
quality
of
clinical
unless absolutely necessary. If necessary,
decision-making related to drug therapy.
the length can be increased to a MAX of
 The tool is also useful for informing patients about their individualized expected
56”. Each square foot costs $10.25.
benefits or risks of drug therapy, thus as an aid to “evidence-based patient choice”.
“Limitations” Box is a reasonable idea.
“References” box is optional.